<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2018</study_start_year><data_sharing_plan>IPD Sharing (as of April 2021): No</data_sharing_plan><condition>Colon Cancer Stage</condition><condition>Colorectal Neoplasms</condition><disease>Colon Cancer Stage</disease><disease>Colorectal Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2282143</full_dataset_link><location>Egypt</location><study_start_month>8</study_start_month><keyword>Celecoxib</keyword><repository>ECRIN MDR</repository><study_status>Recruiting</study_status></additional><is_claimable>false</is_claimable><name>Celecoxib as Adjuvant Therapy to Chemotherapy in Patients With Metastatic Colorectal Cancer</name><description>The study aimed at evaluation of anticancer effect of celecoxib as adjuvant therapy to chemotherapy in patients with metastatic colorectal cancer</description><dates><creation>2018-08-15</creation></dates><accession>2282143</accession><cross_references><ClinicalTrials___gov>NCT03645187</ClinicalTrials___gov></cross_references></HashMap>